225 related articles for article (PubMed ID: 16953265)
1. New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism.
Schulman S; Ogren M
Thromb Haemost; 2006 Sep; 96(3):258-66. PubMed ID: 16953265
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
5. [Idiopathic venous thromboembolic disease. risk factors for recurrence in 2006].
Christiaens L
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):133-8. PubMed ID: 17474499
[TBL] [Abstract][Full Text] [Related]
6. [The optimal duration of anticoagulant treatment following pulmonary embolism].
Couturaud F
Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
Farraj RS
Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
[TBL] [Abstract][Full Text] [Related]
9. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
10. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
[TBL] [Abstract][Full Text] [Related]
11. Emerging anticoagulants for the treatment of venous thromboembolism.
Weitz JI
Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
[TBL] [Abstract][Full Text] [Related]
12. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
[TBL] [Abstract][Full Text] [Related]
13. The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.
Schulman S
Wien Med Wochenschr; 1999; 149(2-4):66-9. PubMed ID: 10378327
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative recurrence of venous thromboembolism in patients with episodes of preoperative thromboembolism].
Kuroiwa M; Arai M; Nakahara E; Hoka S
Masui; 2003 Jul; 52(7):744-9. PubMed ID: 12910975
[TBL] [Abstract][Full Text] [Related]
15. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
Frazee LA; Chomo DL
Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
[TBL] [Abstract][Full Text] [Related]
16. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
17. [Duration of oral anticoagulant therapy in venous thromboembolism].
Pinède L
Rev Med Interne; 2001 Dec; 22(12):1225-36. PubMed ID: 11794893
[TBL] [Abstract][Full Text] [Related]
18. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Baglin T; Luddington R; Brown K; Baglin C
Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
[TBL] [Abstract][Full Text] [Related]
19. Duration of anticoagulation treatment in patients with venous thromboembolism.
Kaatz S; Qureshi W; Fain C; Paje D
J Am Osteopath Assoc; 2010 Nov; 110(11):638-44. PubMed ID: 21135195
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
